NCT07214337Not yet recruiting
Digital Inhaler Use in Obstructive Lung Disease Care
Feasibility, Adoption and Efficacy of Digital Inhaler in the Management of Obstructive Lung Disease
Source: ClinicalTrials.gov · Last updated 9 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a pilot study to evaluate the role digital inhaler technology on patients with obstructive lung disease in preventing admissions and exacerbation, as well as improving symptom control. The primary objective is to evaluate feasibility of study protocol, patient recruitment, and patient retention with goal recruitment of 20 participants, 60% recruitment success, and 60% retention rate for 6 months duration. The secondary objectives are the evaluation of patient admission rate, exacerbation rates, and symptoms control with use of digital inhaler technology The subject population will be patients with physician diagnosed obstructive lung disease.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 2 Oct 2025
- Start date
- 1 Nov 2025
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- Cedars-Sinai Medical Center
- NCT number
- NCT07214337
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 1 Nov 2025 to the primary completion date, 31 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Suffer from any visual, hearing or cognitive impairment that cannot be corrected enough to operate the devices properly. Mild/moderate vision loss and mild hearing loss may be included with appropriate corrective measures that do not affect the device usage.
- Suffering from serious uncontrolled medical conditions that may interfere with study conduct.
Other
- Physically disabled such that they are incapable of using digital devices or metered dose inhalers.
- Inability or unwillingness of the participant to give written informed consent.
- Pregnant women (due to complicated physiology)
- The current study is a feasibility pilot. Based on the results of the study, future studies will likely include pregnant patients as well.
- Prisoners
Who the study is looking for
- Any sex
- Over the age of 18 years.
- Physician-diagnosed obstructive lung disease
- Speak, read, and understand English.
- The current study is a feasibility pilot. Based on the results of the study, future studies will include non-English speakers as well.
- Able to understand study requirements and comply with study procedures.
- Ability to operate a smartphone or tablet (for questionnaire and symptoms input).
- Patients who use either a DPI or an MDI device as controller medications. Medications will not be changed by the study team.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cedars-Sinai Medical Center Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.